Chronic expanding hematoma following Gamma Knife irradiation for primary central nervous system lymphoma: illustrative case.

Etsuko Yamamoto Hattori, Yukinori Terada, Yasuhide Takeuchi, Yasuhide Makino, Shigeki Takada, Noritaka Sano, Masahiro Tanji, Yohei Mineharu, Yoshiki Arakawa
{"title":"Chronic expanding hematoma following Gamma Knife irradiation for primary central nervous system lymphoma: illustrative case.","authors":"Etsuko Yamamoto Hattori, Yukinori Terada, Yasuhide Takeuchi, Yasuhide Makino, Shigeki Takada, Noritaka Sano, Masahiro Tanji, Yohei Mineharu, Yoshiki Arakawa","doi":"10.3171/CASE258","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic expanding hematoma (CEH) is a rare disease characterized by slow expansion, especially reported after Gamma Knife radiosurgery (GKRS) for cerebral arteriovenous malformations. No cases have been reported following treatment for primary central nervous system lymphoma (PCNSL). Vascular endothelial growth factor and vascular endothelial growth factor receptor-1 (VEGFR-1) have been reported to be responsible for CEH induction.</p><p><strong>Observations: </strong>A 56-year-old woman underwent partial tumor removal for PCNSL in the left temporo-occipital lobe at another hospital. One and a half months later, a new lesion was observed, and she underwent GKRS, including the residual lesion. She was treated with multiple chemotherapy regimens including R-MPV (rituximab, methotrexate, procarbazine, vincristine) but relapsed repeatedly and was administered tirabrutinib. Four years after GKRS, the gadolinium-enhanced lesion slowly grew. Tumor recurrence or radiation necrosis was suspected, and surgical removal was performed. The tissue was composed of nonmalignant brain tissue and fibrinized hematoma, which demonstrated strong expression of VEGFR-1 on immunostaining, and the pathological diagnosis was CEH.</p><p><strong>Lessons: </strong>In this patient, CEH could have resulted from VEGFR-1 expression due to GKRS. For a patient with slow lesion growth following GKRS for PCNSL, surgical removal should be considered, taking into account the possibility of CEH along with recurrence and radiation necrosis. https://thejns.org/doi/10.3171/CASE258.</p>","PeriodicalId":94098,"journal":{"name":"Journal of neurosurgery. Case lessons","volume":"9 16","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12013369/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neurosurgery. Case lessons","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3171/CASE258","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Chronic expanding hematoma (CEH) is a rare disease characterized by slow expansion, especially reported after Gamma Knife radiosurgery (GKRS) for cerebral arteriovenous malformations. No cases have been reported following treatment for primary central nervous system lymphoma (PCNSL). Vascular endothelial growth factor and vascular endothelial growth factor receptor-1 (VEGFR-1) have been reported to be responsible for CEH induction.

Observations: A 56-year-old woman underwent partial tumor removal for PCNSL in the left temporo-occipital lobe at another hospital. One and a half months later, a new lesion was observed, and she underwent GKRS, including the residual lesion. She was treated with multiple chemotherapy regimens including R-MPV (rituximab, methotrexate, procarbazine, vincristine) but relapsed repeatedly and was administered tirabrutinib. Four years after GKRS, the gadolinium-enhanced lesion slowly grew. Tumor recurrence or radiation necrosis was suspected, and surgical removal was performed. The tissue was composed of nonmalignant brain tissue and fibrinized hematoma, which demonstrated strong expression of VEGFR-1 on immunostaining, and the pathological diagnosis was CEH.

Lessons: In this patient, CEH could have resulted from VEGFR-1 expression due to GKRS. For a patient with slow lesion growth following GKRS for PCNSL, surgical removal should be considered, taking into account the possibility of CEH along with recurrence and radiation necrosis. https://thejns.org/doi/10.3171/CASE258.

伽玛刀照射治疗原发性中枢神经系统淋巴瘤后慢性扩张性血肿:说明性病例。
背景:慢性扩张性血肿(CEH)是一种以缓慢扩张为特征的罕见疾病,特别是在伽玛刀放射治疗脑动静脉畸形(GKRS)后报道。没有病例报告后治疗原发性中枢神经系统淋巴瘤(PCNSL)。据报道,血管内皮生长因子和血管内皮生长因子受体-1 (VEGFR-1)与CEH诱导有关。观察:一名56岁女性在另一家医院接受了左侧颞枕叶PCNSL部分肿瘤切除术。1个半月后发现新病灶,行GKRS,包括残余病灶。她接受了包括R-MPV(利妥昔单抗、甲氨蝶呤、丙卡嗪、长春新碱)在内的多种化疗方案治疗,但反复复发,并给予了替拉替尼。GKRS四年后,钆增强病变缓慢增长。怀疑肿瘤复发或放射性坏死,行手术切除。组织由非恶性脑组织和纤化血肿组成,免疫染色显示VEGFR-1强烈表达,病理诊断为CEH。结论:在该患者中,CEH可能是由GKRS引起的VEGFR-1表达引起的。对于GKRS治疗PCNSL后病变生长缓慢的患者,考虑到CEH、复发和放射性坏死的可能性,应考虑手术切除。https://thejns.org/doi/10.3171/CASE258。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信